{"id":954632,"date":"2026-04-24T15:27:04","date_gmt":"2026-04-24T19:27:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/"},"modified":"2026-04-24T15:27:04","modified_gmt":"2026-04-24T19:27:04","slug":"medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/","title":{"rendered":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nMEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop<\/p>\n<p>\nMedpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.<\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nLeading securities law firm <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=Bleichmar+Fonti+%26amp%3B+Auld+LLP&amp;index=1&amp;md5=fe801477d0cdb0ea123aadb78a480c46\"><b>Bleichmar Fonti &amp; Auld LLP<\/b><\/a> announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company\u2019s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.<\/p>\n<p>\nIf you invested in Medpace, you are encouraged to obtain additional information by visiting: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;index=2&amp;md5=14f8f7a1124095c241fecbc02e4c4e11\"><b>https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit<\/b><\/a><b>.<\/b><\/p>\n<p><b>Key Details of the Medpace ($MEDP) Class Action:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Lead Plaintiff Deadline: <\/b>June 8, 2026\n<\/li>\n<li><b>Alleged Misconduct: <\/b>Securities fraud regarding Medpace\u2019s alleged understatement of cancellation rates and overstatement of book-to-bill ratio.\n<\/li>\n<li><b>Largest Alleged Stock Decline: <\/b>February 9, 2026 \u2013 15.9% Stock Drop\n<\/li>\n<li><b>Court: <\/b>U.S. District Court for the Southern District of Ohio\n<\/li>\n<li><b>Action: <\/b>Contact <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=BFA+Law&amp;index=3&amp;md5=10ec40da88e86d2d90bdb80f834cfce8\">BFA Law<\/a> to discuss your rights\n<\/li>\n<\/ul>\n<p>\nInvestors have until June 8, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Medpace common stock. The case is pending in the U.S. District Court for the Southern District of Ohio. It is captioned <i>Durbin v. Medpace Holdings Inc., et al.<\/i>, No. 1:26-cv-00346.<\/p>\n<p><b>Why is Medpace Being Sued For Securities Fraud?<\/b><\/p>\n<p>\nMedpace is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.<\/p>\n<p>\nDuring the relevant period, Medpace allegedly misled investors concerning its book-to-bill ratio for 4Q 25. According to Medpace, \u201cour award notifications were strong. Cancellations were down across the pipeline.\u201d Medpace also discussed how cancellations were \u201cvery well behaved.\u201d<\/p>\n<p>\nAs alleged, in truth, Medpace\u2019s cancellations had increased causing its book-to-bill ratio to decline.<\/p>\n<p><b>Why did Medpace\u2019s Stock Drop?<\/b><\/p>\n<p>\nOn February 9, 2026, Medpace released its 4Q 2025 financial results, reporting that its book-to-bill ratio declined to 1.04 due to elevated cancellations.<\/p>\n<p>\nThis news caused the price of Medpace stock to drop nearly 16%, from $530.35 per share on February 9, 2026 to 446.05 per share on February 10, 2026.<\/p>\n<p>\nBFA is also investigating recent reports that Medpace\u2019s cancellations continued to increase and book-to-bill ratio continued to decline, reaching as low as 0.88 for 1Q 26. The company\u2019s President, Jesse Geiger, also announced his intention to resign.<\/p>\n<p>\nOn this news, the price of the company\u2019s stock declined roughly 23% during afternoon trading on April 23, 2026.<\/p>\n<p><b>Click here for more information: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;index=4&amp;md5=dc4dc8023a9ddc7066771df8399ddb0d\"><b>https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit<\/b><\/a><b>.<\/b><\/p>\n<p><b>What Can You Do?<\/b><\/p>\n<p>\nIf you invested in Medpace, you may have legal options and are encouraged to submit your information to the firm.<\/p>\n<p>\nAll representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n<p><b>Submit your information by visiting:<\/b><\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;index=5&amp;md5=6b93e6e0181efa6c64fa124c358fd908\"><b>https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit<\/b><\/a><\/p>\n<p>\nOr contact:<\/p>\n<p>\nAdam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>Why Bleichmar Fonti &amp; Auld LLP?<\/b><\/p>\n<p>\nBFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by <i>Chambers USA<\/i>, <i>The Legal 500<\/i>, and <i>ISS SCAS<\/i>, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the <i>National Law Journal<\/i>, \u201cLitigation Stars\u201d by <i>Benchmark Litigation<\/i>, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by <i>Lawdragon<\/i>, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by <i>Law360<\/i> and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n<p>\nFor more information about BFA and its attorneys, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com&amp;index=6&amp;md5=2e326a358b4f9eae4885f6e77caf93a4\">https:\/\/www.bfalaw.com<\/a>.<\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;esheet=54522558&amp;newsitemid=20260424518209&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fmedpace-class-action-lawsuit&amp;index=7&amp;md5=dfad0f8af6928dfd3850fc8948d5649e\"><b>https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit<\/b><\/a><\/p>\n<p><i>Attorney advertising. Past results do not guarantee future outcomes.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260424518209\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260424518209\/en\/<\/a><\/span><\/p>\n<p>\nAdam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260424518209\/en\/2784757\/3\/BFA_Law_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company\u2019s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Medpace, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit. Key Details of the Medpace ($MEDP) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954632","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company\u2019s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Medpace, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit. Key Details of the Medpace ($MEDP) &hellip; Continue reading &quot;MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-24T19:27:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop\",\"datePublished\":\"2026-04-24T19:27:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/\"},\"wordCount\":701,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/\",\"name\":\"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-04-24T19:27:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/","og_locale":"en_US","og_type":"article","og_title":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk","og_description":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company\u2019s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Medpace, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/medpace-class-action-lawsuit. Key Details of the Medpace ($MEDP) &hellip; Continue reading \"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-24T19:27:04+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop","datePublished":"2026-04-24T19:27:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/"},"wordCount":701,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/","name":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-04-24T19:27:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260424518209r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medp-class-action-medpace-sued-for-securities-fraud-after-cancellation-rates-lead-to-16-stock-drop\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954632"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954632\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}